Drugs / G-CSF
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT06763666 Background | Feb → Jun 2025 overdue | acute myeloid leukemia | Nanfang Hospital, Southern Medical University | Not yet recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | G-CSF | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06763666 ↗ |
| Route | Subcutaneous | “The dose of G-CSF was 5ug/kg/d subcutaneously injected on days 0-5.” NCT06763666 ↗ |